Control of fetal hemoglobin: new insights emerging from genomics and clinical implications
Open accessThe DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Abstract
Increased levels of fetal hemoglobin (HbF, alpha(2)gamma(2)) are of no consequence in healthy adults, but confer major clinical benefits in patients with sickle cell anemia (SCA) and beta thalassemia, diseases that represent major public health problems. Inter-individual HbF variation is largely genetically controlled, with one extreme caused by mutations involving the beta globin gene (HBB) complex, historically referred to as pancellular hereditary persistence of fetal hemoglobin (HPFH). These Mendelian forms of HPFH are rare and do not explain the common form of heterocellular HPFH which represents the upper tail of normal HbF variation, and is clearly inherited as a quantitative genetic trait. Genetic studies have identified three major quantitative trait loci (QTLs) (Xmn1-HBG2, HBS1L-MYB intergenic region on chromosome 6q23, and BCL11A on chromosome 2p16) that account for 20-50% of the common variation in HbF levels in patients with SCA and beta thalassemia, and in healthy adults. Two of the major QTLs include oncogenes, emphasizing the importance of cell proliferation and differentiation as an important contribution to the HbF phenotype. The review traces the story of HbF quantitative genetics that uncannily mirrors the changing focus in genetic methodology, from candidate genes through positional cloning, to genome-wide association, that have expedited the dissection of the genetic architecture underlying HbF variability. These genetic results have already provided remarkable insights into molecular mechanisms that underlie the hemoglobin 'switch'.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
The Wellcome Trust Case Control Consortium, Management Committee, Burton, P. R., Clayton, D. G., Cardon, L. R., Craddock, N., Deloukas, P., Duncanson, A., Kwiatkowski, D. P., McCarthy, M. I., et al. (2007) · Nature · doi:10.1038/nature05911 · Cited by 9,442
The American Journal of Human Genetics
S., J. (1950) · Population (French Edition) · doi:10.2307/1523704 · Cited by 5,028
Genome-wide association studies for complex traits: consensus, uncertainty and challenges
McCarthy, M. I., Abecasis, G. R., Cardon, L. R., Goldstein, D. B., Little, J., Ioannidis, J. P. A., & Hirschhorn, J. N. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2344 · Cited by 2,891 · cited 1×
“Identifying the common alleles will require large population samples for additional screening studies and even larger samples for replication, and possibly denser maps (62).”
BackgroundThe Wellcome Trust Case Control Consortium, U.K.
Mossman, K. (2008) · Scientific American · doi:10.1038/scientificamerican0108-42a · Cited by 2,684
Genetic Mapping in Human Disease
Altshuler, D., Daly, M. J., & Lander, E. S. (2008) · Science · doi:10.1126/science.1156409 · Cited by 1,452
Common variants at 30 loci contribute to polygenic dyslipidemia
Kathiresan, S., Willer, C. J., Peloso, G. M., Demissie, S., Musunuru, K., Schadt, E. E., Kaplan, L., Bennett, D., Li, Y., Tanaka, T., et al. (2009) · Nature Genetics · doi:10.1038/ng.291 · Cited by 1,364
Self-citationCommon and rare variants in multifactorial susceptibility to common diseases
Bodmer, W., & Bonilla, C. (2008) · Nature Genetics · doi:10.1038/ng.f.136 · Cited by 1,131
Common Genetic Variation and Human Traits
Goldstein, D. B. (2009) · New England Journal of Medicine · doi:10.1056/nejmp0806284 · Cited by 920 · cited 1×
“Identification of rare alleles will also require next-generation DNA sequencing technologies and statistical analysis methods that enable genomewide sequence analysis in large samples (63).”
MethodHuman Fetal Hemoglobin Expression Is Regulated by the Developmental Stage-Specific Repressor BCL11A
Sankaran, V. G., Menne, T. F., Xu, J., Akie, T. E., Lettre, G., Van Handel, B., Mikkola, H. K. A., Hirschhorn, J. N., Cantor, A. B., & Orkin, S. H. (2008) · Science · doi:10.1126/science.1165409 · Cited by 919
A HapMap harvest of insights into the genetics of common disease
Manolio, T. A., Brooks, L. D., & Collins, F. S. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34772 · Cited by 889
Cited by
Fetal hemoglobin in sickle cell anemia
Akinsheye, I., Alsultan, A., Solovieff, N., Ngo, D., Baldwin, C. T., Sebastiani, P., Chui, D. H. K., & Steinberg, M. H. (2011) · Blood · doi:10.1182/blood-2011-03-325258 · Cited by 553
“Individual variants and haplotypes at this locus account for up to 18% of HbF variance sickle cell anemia.(55) 8q A QTL at chromosome 8q appeared to interact with the HBG2 -158 C-T SNP to modulate HbF levels.”
Genetic adaptation to high altitude in the Ethiopian highlands
Scheinfeldt, L. B., Soi, S., Thompson, S., Ranciaro, A., Woldemeskel, D., Beggs, W., Lambert, C., Jarvis, J. P., Abate, D., Belay, G., et al. (2012) · Genome Biology · doi:10.1186/gb-2012-13-1-r1 · Cited by 447
“hemoglobin levels [27], CBARA1 (which was also identified in the LSBL analysis) and VAV3, which induces”
BackgroundHiggs, D. R., Engel, J. D., & Stamatoyannopoulos, G. (2012) · The Lancet · doi:10.1016/s0140-6736(11)60283-3 · Cited by 434
Borg, J., Papadopoulos, P., Georgitsi, M., Gutiérrez, L., Grech, G., Fanis, P., Phylactides, M., Verkerk, A. J. M. H., van der Spek, P. J., Scerri, C. A., et al. (2010) · Nature Genetics · doi:10.1038/ng.630 · Cited by 371
Xu, J., Sankaran, V. G., Ni, M., Menne, T. F., Puram, R. V., Kim, W., & Orkin, S. H. (2010) · Genes & Development · doi:10.1101/gad.1897310 · Cited by 361
“Recent human genetic studies focused on natural variation in the level of HbF expression in human populations shed new light on this complex regulatory process (Thein and Menzel 2009; Thein et al. 2009).”
BackgroundGenetic modifiers of sickle cell disease
Steinberg, M. H., & Sebastiani, P. (2012) · American Journal of Hematology · doi:10.1002/ajh.23232 · Cited by 315
“Individual variants and haplotypes at this locus accounted for up to 18% of HbF variance sickle cell anemia [98].”
BackgroundFamily-based designs for genome-wide association studies
Ott, J., Kamatani, Y., & Lathrop, M. (2011) · Nature Reviews Genetics · doi:10.1038/nrg2989 · Cited by 271
Self-citationIthaGenes: An Interactive Database for Haemoglobin Variations and Epidemiology
Kountouris, P., Lederer, C. W., Fanis, P., Feleki, X., Old, J., & Kleanthous, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103020 · Cited by 270
“globin genes, such as the levels of foetal haemoglobin (Hb F) [33].”
BackgroundCorepressor-dependent silencing of fetal hemoglobin expression by BCL11A
Xu, J., Bauer, D. E., Kerenyi, M. A., Vo, T. D., Hou, S., Hsu, Y.-J., Yao, H., Trowbridge, J. J., Mandel, G., & Orkin, S. H. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1303976110 · Cited by 233
“Recent genomewide association studies (GWAS) led to the identification of a new HbF-associated locus on chromosome 2, located within the gene BCL11A (3).”
BackgroundTranscriptional regulation of fetal to adult hemoglobin switching: new therapeutic opportunities
Wilber, A., Nienhuis, A. W., & Persons, D. A. (2011) · Blood · doi:10.1182/blood-2010-11-316893 · Cited by 215
MicroRNA-15a and -16-1 act via MYB to elevate fetal hemoglobin expression in human trisomy 13
Sankaran, V. G., Menne, T. F., Šćepanović, D., Vergilio, J.-A., Ji, P., Kim, J., Thiru, P., Orkin, S. H., Lander, E. S., & Lodish, H. F. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1018384108 · Cited by 215
“This was particularly notable, because common genetic variants from genomewide association studies have suggested that polymorphisms in the MYB locus are important mediators of variation in HbF levels in humans (25), which is further supported by the finding that overexpression of MYB in cell lines causes a decrease i…”
BackgroundAdvances in the understanding of haemoglobin switching
Sankaran, V. G., Xu, J., & Orkin, S. H. (2010) · British Journal of Haematology · doi:10.1111/j.1365-2141.2010.08105.x · Cited by 214
“More recently, recognized variability in the expression of HbF both in non-anaemic individuals and patients with b-haemoglobin disorders stimulated efforts to utilize new human genetic approaches to delineate factors that might explain this variation (Thein & Menzel, 2009; Thein et al, 2009).”
BackgroundMolecular basis of β thalassemia and potential therapeutic targets
Thein, S. L. (2018) · Blood Cells, Molecules, and Diseases · doi:10.1016/j.bcmd.2017.06.001 · Cited by 209
Self-citationHBS1L-MYB intergenic variants modulate fetal hemoglobin via long-range MYB enhancers
Stadhouders, R., Aktuna, S., Thongjuea, S., Aghajanirefah, A., Pourfarzad, F., van IJcken, W., Lenhard, B., Rooks, H., Best, S., Menzel, S., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci71520 · Cited by 209
“As elevated HbF levels ameliorate the severity of β -thalassemia and sickle cell anemia, induction of HbF in adults has been a major focus of research in the past decades (16, 17).”
Self-citationA Functional Element Necessary for Fetal Hemoglobin Silencing
Sankaran, V. G., Xu, J., Byron, R., Greisman, H. A., Fisher, C., Weatherall, D. J., Sabath, D. E., Groudine, M., Orkin, S. H., Premawardhena, A., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1103070 · Cited by 184
Vasculopathy and pulmonary hypertension in sickle cell disease
Potoka, K. P., & Gladwin, M. T. (2015) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00252.2014 · Cited by 133
Quinn, C. T. (2016) · Experimental Biology and Medicine · doi:10.1177/1535370216640385 · Cited by 136
“This variation in HbF is largely genetically determined.(11) HbF expression is regulated by a number of determinants, both linked and unlinked to b-globin locus.”
BackgroundFarrell, J. J., Sherva, R. M., Chen, Z.-Y., Luo, H.-Y., Chu, B. F., Ha, S. Y., Li, C. K., Lee, A. C. W., Li, R. C. H., Li, C. K., et al. (2011) · Blood · doi:10.1182/blood-2010-11-317081 · Cited by 117
Hirschhorn, J. N., & Gajdos, Z. K. Z. (2010) · Annual Review of Medicine · doi:10.1146/annurev.med.091708.162036 · Cited by 119
“HbF levels are an important modifier of the severity of sickle-cell disease, thalassemia, and other hemoglobinopathies, and are under genetic regulation, partially explained by rare and common cis-acting variation at the globin locus (21).”
BackgroundGenome Wide Association Study of Fetal Hemoglobin in Sickle Cell Anemia in Tanzania
Mtatiro, S. N., Singh, T., Rooks, H., Mgaya, J., Mariki, H., Soka, D., Mmbando, B., Msaki, E., Kolder, I., Thein, S. L., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111464 · Cited by 105
“GWAS have been previously applied in the identification of genetic variants that regulate levels of HbF, both in healthy individuals and those with SCA [5–8,12].”
BackgroundSelf-citationPule, G. D., Mowla, S., Novitzky, N., Wiysonge, C. S., & Wonkam, A. (2015) · Expert Review of Hematology · doi:10.1586/17474086.2015.1078235 · Cited by 113
“Genetic variants at three principal loci, BCL11A, HBS1L-MYB and HBB cluster, account for 10–20% of HbF variation [12–14]; among SCD patients in the US and Brazil [15], Tanzania [16] and Cameroon [17].”
BackgroundGenetics of fetal hemoglobin in Tanzanian and British patients with sickle cell anemia
Makani, J., Menzel, S., Nkya, S., Cox, S. E., Drasar, E., Soka, D., Komba, A. N., Mgaya, J., Rooks, H., Vasavda, N., et al. (2011) · Blood · doi:10.1182/blood-2010-08-302703 · Cited by 101
“Genetic variants at three principal loci have been shown to contribute to the inter-individual HbF variation in sickle patients((5-7)) – the region on chromosome 11p that contains the HBB and olfactory receptor gene clusters((8)) and two hematopoietic regulator loci, one on chromosome 6q (HBS1L-”
Self-citationNeurovascular coupling and energy metabolism in the developing brain
Kozberg, M. G., & Hillman, E. M. C. (2016) · Progress in brain research · doi:10.1016/bs.pbr.2016.02.002 · Cited by 110
“Human infants continue to generate significant amounts of fetal hemoglobin for up to 6 months postnatally (Thein et al., 2009), which impacts (diminishes) oxygen exchange between the vasculature and tissue throughout the body, including in the brain.”
BackgroundGene therapy for sickle cell disease: moving from the bench to the bedside
Abraham, A., & Tisdale, J. F. (2021) · Blood · doi:10.1182/blood.2019003776 · Cited by 111
Ready for Repair? Gene Editing Enters the Clinic for the Treatment of Human Disease
Ernst, M. P. T., Broeders, M., Herrero-Hernandez, P., Oussoren, E., van der Ploeg, A. T., & Pijnappel, W. W. M. P. (2020) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2020.06.022 · Cited by 107
“There is a difference in HbF protein levels among b-thalassemia patients, and this has been linked to several genetic variants, with single nucleotide variants (SNVs) in the BCL11A gene correlating most strongly with HbF expression.(256) Reduced BCL11A protein expression is correlated with increased HbF protein expres…”
BackgroundRecent trends in the gene therapy of β-thalassemia
Gambari, R., Finotti, A., Breda, L., Lederer, C. W., Bianchi, N., Zuccato, C., Klenathous, M., & Rivella, S. (2015) · Journal of Blood Medicine · doi:10.2147/jbm.s46256 · Cited by 106
Gallienne, A. E., Dreau, H. M.-P., Schuh, A., Old, J. M., & Henderson, S. J. (2011) · Haematologica · doi:10.3324/haematol.2011.055442 · Cited by 88
“shown to account for 50% of the variance seen in Hb F levels indicating that additional loci must be involved.(8) Recently, an additional potential locus was identified when point mutations in the KLF1 gene were found to be associated with HPFH in a Maltese(9) family and in a family from Sardinia.”
BackgroundBadens, C., Joly, P., Agouti, I., Thuret, I., Gonnet, K., Fattoum, S., Francina, A., Simeoni, M.-C., Loundou, A., & Pissard, S. (2011) · Haematologica · doi:10.3324/haematol.2011.046748 · Cited by 77
“An increased residual level of HbF in adult life which compensates the decreased b-globin chain is also a major determinant of less severe disease.(5) Three major HbF Quantitative Trait Loci (QTL), accounting for 20-50% of HbF variation, have been identified so far.”
BackgroundTranscription regulation by distal enhancers: Who’s in the loop?
Stadhouders, R., van den Heuvel, A., Kolovos, P., Jorna, R., Leslie, K., Grosveld, F., & Soler, E. (2012) · Transcription · doi:10.4161/trns.20720 · Cited by 58
Chen, P., Takeuchi, F., Lee, J.-Y., Li, H., Wu, J.-Y., Liang, J., Long, J., Tabara, Y., Goodarzi, M. O., Pereira, M. A., et al. (2014) · Diabetes · doi:10.2337/db13-1815 · Cited by 69
Guilcher, G. M. T., Truong, T. H., Saraf, S. L., Joseph, J. J., Rondelli, D., & Hsieh, M. M. (2018) · Seminars in Hematology · doi:10.1053/j.seminhematol.2018.04.011 · Cited by 73
Genetic Basis and Genetic Modifiers of β-Thalassemia and Sickle Cell Disease
Thein, S. L. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-1-4939-7299-9_2 · Cited by 70
Self-citationFetal hemoglobin in sickle cell anemia: Genetic studies of the Arab-Indian haplotype
Ngo, D., Bae, H., Steinberg, M. H., Sebastiani, P., Solovieff, N., Baldwin, C. T., Melista, E., Safaya, S., Farrer, L. A., Al-Suliman, A. M., et al. (2013) · Blood Cells, Molecules, and Diseases · doi:10.1016/j.bcmd.2012.12.005 · Cited by 58
“SNPs in these loci accounted for 15 to 30% of the HbF phenotypic variation in African American sickle cell anemia.(2, 4-7, 35) Among AI haplotype homozygotes, variants in BCL11A accounted for 7.”
BackgroundImmunological and regenerative properties of cord blood stem cells
Francese, R., & Fiorina, P. (2010) · Clinical Immunology · doi:10.1016/j.clim.2010.04.010 · Cited by 61
Fetal hemoglobin in sickle cell anemia: The Arab‐Indian haplotype and new therapeutic agents
Habara, A. H., Mohammed, E. S. E., & Steinberg, M. H. (2017) · American Journal of Hematology · doi:10.1002/ajh.24872 · Cited by 60
“Among African-origin HbS gene haplotypes, polymorphisms in BCL11A and MYB, the major trans-acting repressors of HBG, accounted for 10– 50% of HbF variance.(46,47) In contrast, MYB appeared to play a minor regulatory role in the AI haplotype because of the rarity of the functional 3-bp deletion in one of its enhancers.”
BackgroundSwitching from fetal to adult hemoglobin
Wang, X., & Thein, S. L. (2018) · Nature Genetics · doi:10.1038/s41588-018-0094-z · Cited by 55
Self-citationRecent Advances in β-Thalassemias
Cao, A., Moi, P., & Galanello, R. (2011) · Pediatric Reports · doi:10.4081/pr.2011.e17 · Cited by 53
Goodman, M., & Malik, P. (2016) · Therapeutic Advances in Hematology · doi:10.1177/2040620716653729 · Cited by 52
“Normally the β-globin family members γ- and δ-globin are expressed only at very low levels (<2%) after terminal hemoglobin switching to HbA, and are unable to compensate for hemoglobinopathies [Thein et al. 2009].”
BackgroundCardoso, G. L., Diniz, I. G., da Silva, A. N. L. M., Cunha, D. A., da Silva, J. S., Uchôa, C. T. C., dos Santos, S. E. B., Trindade, S. M. S., Cardoso, M. D. S. D. O., & Guerreiro, J. F. (2014) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2014.07.006 · Cited by 52
“Previous genetic association studies found single nucleotide polymorphisms (SNPs) in the Gγglobin (HBG2) gene promoter (chromosome 11p) in BCL11A (chromosome 2p) regions and in HBS1L-MYB intergenic polymorphism (HMIP; chromosome 6q) associated with HbF levels (reviewed in [3,4]).”
BackgroundFetal globin expression is regulated by Friend of Prmt1
van Dijk, T. B., Gillemans, N., Pourfarzad, F., van Lom, K., Lindern, M. V., Grosveld, F. G., & Philipsen, S. (2010) · Blood · doi:10.1182/blood-2010-03-274399 · Cited by 51
Morrison, T. A., Wilcox, I., Luo, H., Farrell, J. J., Kurita, R., Nakamura, Y., Murphy, G. J., Cui, S., Steinberg, M. H., & Chui, D. H. K. (2017) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2017.11.003 · Cited by 51
“Genome-wide association studies (GWAS) have found multiple single nucleotide polymorphisms (SNPs) marking three major quantitative trait loci (QTL) associated with HbF levels — chr11p15 (HBB gene cluster), chr2p16 (BCL11A) and chr6q23 (HBS1L-MYB intergenic polymorphisms or HMIP) [3].”
BackgroundGenetic modifiers of HbF and response to hydroxyurea in sickle cell disease
Green, N., & Barral, S. (2010) · Pediatric Blood & Cancer · doi:10.1002/pbc.22754 · Cited by 50
“A genome-wide linkage analysis of Asian-Indian kindred with probands showing mild SCD identified a major locus on chromosome 6q23 [9].”
BackgroundInfluentialSIRT1 activates the expression of fetal hemoglobin genes
Dai, Y., Chen, T., Ijaz, H., Cho, E. H., & Steinberg, M. H. (2017) · American Journal of Hematology · doi:10.1002/ajh.24879 · Cited by 49
Banan, M., Bayat, H., Azarkeivan, A., Mohammadparast, S., Kamali, K., Farashi, S., Bayat, N., Khani, M. H., Neishabury, M., & Najmabadi, H. (2012) · Hemoglobin · doi:10.3109/03630269.2012.691147 · Cited by 48
“The selection of these SNPs was based on their strong correlation with Hb F and F-cell levels in African, Asian, Caribbean and European populations (16).”
Backgroundβ-Thalassemia Intermedia in Northern Iraq: A Single Center Experience
Al-Allawi, N. A. S., Jalal, S. D., Mohammad, A. M., Omer, S. Q., & Markous, R. S. D. (2014) · BioMed Research International · doi:10.1155/2014/262853 · Cited by 47
Kountouris, P., Stephanou, C., Archer, N. M., Bonifazi, F., Giannuzzi, V., Kuo, K. H. M., Maggio, A., Makani, J., Mañú‐Pereira, M. D. M., Michailidou, K., et al. (2021) · American Journal of Hematology · doi:10.1002/ajh.26323 · Cited by 47
“Several genome-wide analyses have identified three major quantitative trait loci modulating HbF levels: a promoter variant on HBG2 (XmnI-rs7482144), the HBS1LMYB intergenic region and BCL11A, which together explain up to 50% of the genetic variation affecting HbF.1,2 More recently, studies have identified genetic modi…”
BackgroundPrediction of Disease and Phenotype Associations from Genome-Wide Association Studies
Lewis, S. N., Nsoesie, E. O., Weeks, C., Qiao, D., & Zhang, L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027175 · Cited by 47
“For example, haematological traits are those that determine leukocyte, erythrocyte, and platelet phenotypes [25], while fetal hemoglobin levels have been linked to diagnosis of erythrocyte-associated diseases, such as sickle cell anemia [26].”
BackgroundSoni, S. (2020) · American Journal of Hematology · doi:10.1002/ajh.25909 · Cited by 42
“Hence, caution is necessary when estimating the degree of modification (gene-insertion or edits) needed with gene therapy products for clinical benefit, compared to the level of mixed chimerism achieved after a pan-cellular correction with allogeneic HSCT or seen in patients with HPFH.69 Hb-F induction post-transplant…”
Akinsheye, I., Solovieff, N., Ngo, D., Malek, A., Sebastiani, P., Steinberg, M. H., & Chui, D. H. K. (2012) · American Journal of Hematology · doi:10.1002/ajh.22221 · Cited by 40
“BCL11A polymorphisms correlate highly with HbF levels in SCA, accounting for 7–12% of the HbF variance [6].”
BackgroundPostnatal Prediction of Gestational Age Using Newborn Fetal Hemoglobin Levels
Wilson, K. R., Hawken, S., Murphy, M. S. Q., Atkinson, K. M., Potter, B. K., Sprague, A. E., Walker, M. C., Chakraborty, P. K., & Little, J. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.11.032 · Cited by 42
“Hemoglobin production naturally shifts with advancing gestation from HbF to HbA such that HbF reserves are typically depleted by six months of age (Bank, 2006; Stamatoyannopoulos, 2005), and while residual amounts of HbF continue to be synthesized in adult erythropoiesis, the majority of adults have b1% HbF (Thein et…”
BackgroundGenetic epidemiology of hemoglobinopathies among Iraqi Kurds
Al-Allawi, N. A. S., Allawi, S. A., & Jalal, S. D. (2020) · Journal of Community Genetics · doi:10.1007/s12687-020-00495-z · Cited by 41
Targeted Fetal Hemoglobin Induction for Treatment of Beta Hemoglobinopathies
Perrine, S. P., Pace, B. S., & Faller, D. V. (2014) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2013.11.009 · Cited by 40
Pereira, C., Relvas, L., Bento, C., Abade, A., Ribeiro, L., & Manco, L. (2015) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2015.02.001 · Cited by 40
“Regarding the HBS1L-MYB intergenic region (HMIP), the most significant associated SNP in betathalassemia and sickle cell anemia among Chinese, European, and African patients, was rs9399137, located at the haplotype block 2 [1].”
BackgroundInfluentialGenetic Modifiers of Sickle Cell Disease
Thein, S. L. (2011) · Hemoglobin · doi:10.3109/03630269.2011.615876 · Cited by 40
Self-citationFucharoen, S., Inati, A. C., Siritanaratku, N., Thein, S. L., Wargin, W. C., Koussa, S., Taher, A. T., Chaneim, N., Boosalis, M. S., BERENSON, R. J., et al. (2013) · British Journal of Haematology · doi:10.1111/bjh.12304 · Cited by 39
“A wide spectrum of clinical severity occurs in the b-thalassaemias, related to the >200 globin molecular mutations and secondary genetic modifiers (Garner et al, 1998; Jiang et al, 2006; Thein & Menzel, 2009; Thein et al, 2009; Nuinoon et al, 2010).”
BackgroundSelf-citationChallenges in chronic transfusion for patients with thalassemia
Lal, A. (2020) · Hematology · doi:10.1182/hematology.2020000102 · Cited by 39
Carobbio, A., Finazzi, G., Thiele, J., Kvasnicka, H. M., Passamonti, F., Rumi, E., Ruggeri, M., Rodeghiero, F., Randi, M. L., Bertozzi, I., et al. (2011) · American Journal of Hematology · doi:10.1002/ajh.22241 · Cited by 39
Green, N., Ender, K. L., Pashankar, F., Driscoll, C., Giardina, P. J., Mullen, C. A., Clark, L. N., Manwani, D. G., Crotty, J., Kisselev, S., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055709 · Cited by 39
“Children with sickle cell disease generally have higher baseline HbF levels than adults and more pronounced HbF response to hydroxyurea [5,6,7,8,9,11,13,16,18,19,20,26].”
BackgroundA systematic review of the literature for severity predictors in children with sickle cell anemia
Meier, E. R., Fasano, R. M., & Levett, P. (2017) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2017.01.014 · Cited by 38
“Genetic analysis would eliminate the age-related variability of HbF levels, but not all since BCL11A is only responsible for 20–50% of the variability in HbF levels in humans [27].”
BackgroundUsing newborn screening analytes to identify cases of neonatal sepsis
Fell, D. B., Hawken, S., Wong, C. A., Wilson, L. A., Murphy, M. S. Q., Chakraborty, P. K., Lacaze‐Masmonteil, T., Potter, B. K., & Wilson, K. R. (2017) · Scientific Reports · doi:10.1038/s41598-017-18371-1 · Cited by 37
Shariati, L., Rohani, F., Hafshejani, N. H., Kouhpayeh, S., Boshtam, M., Mirian, M., Rahimmanesh, I., Hejazi, Z., Modarres, M., Pieper, I. L., et al. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.27253 · Cited by 37
Epigenetic therapies for non-oncology indications
Best, J. D., & Carey, N. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2010.10.006 · Cited by 37
New insights from monogenic diabetes for “common” type 2 diabetes
Tallapragada, D. S. P., Bhaskar, S., & Chandak, G. R. (2015) · Frontiers in Genetics · doi:10.3389/fgene.2015.00251 · Cited by 35
“Together, they account for 20–50% of the variance in HbF levels, illustrating the importance of other genetic loci in modifying disease severity (Menzel and Thein, 2009; Thein et al., 2009).”
BackgroundIncreased blood‐oxygen binding affinity in Tibetan and Han Chinese residents at 4200 m
Simonson, T. S., Wei, G., Wagner, H. E., Wuren, T., Bui, A., Fine, J. M., Ga, Q., Beltrami, F. G., Ma, Y., Wagner, P. D., et al. (2014) · Experimental Physiology · doi:10.1113/expphysiol.2014.080820 · Cited by 34
“…that genetic changes in protein-coding variants, such as those reported in high-altitude deer mice (Natarajan et al. 2013), and/or alterations in regulatory regions, which control Hb isoform levels that naturally vary among humans (Thein et al. 2009), may be associated with P50 in Tibetans.”
Molecular Basis of Thalassemia
Grosso, M., Sessa, R., Puzone, S., Rosaria, M., & Izzo, P. (2012) · InTech eBooks · doi:10.5772/31362 · Cited by 34
“HbF levels vary considerably not only in thalassemic patients but also in healthy adults, where it represents a benign and clinically silent condition (Thein et al., 2009; Weatherall, 2001).”
InfluentialFriedrisch, J. R., Sheehan, V., Flanagan, J. M., Baldan, A., Summarell, C. C. G., Bittar, C. M., Friedrisch, B. K., Wilke, I. I., Ribeiro, C. B., Daudt, L. E., et al. (2016) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2016.11.002 · Cited by 34
Nkya, S. W., Makani, J., Mmbando, B. P., Thein, S. L., Menzel, S., & Cox, S. E. (2014) · American Journal of Hematology · doi:10.1002/ajh.23859 · Cited by 34
“BCL11A acts as a repressor of g globin gene expression, whereas genetic variation near MYB (termed HMIP-2, HBS1L-MYB intergenic polymorphism, block 2) affects the levels of HbF indirectly by altering the kinetics of erythropoiesis [3].”
BackgroundSelf-citationMolecular Basis of β-Thalassemia Intermedia in Erbil Province of Iraqi Kurdistan
Shamoon, R., Al-Allawi, N. A. S., Cappellini, M. D., Pierro, E. D., Brancaleoni, V., & Granata, F. (2015) · Hemoglobin · doi:10.3109/03630269.2015.1032415 · Cited by 33
“’’ The XmnI polymorphism is a major QTL of Hb F production (5,6).”
BackgroundLeonardo, F. C., Brugnerotto, A. F., Domingos, I. F., Fertrin, K. Y., de Albuquerque, D. M., Bezerra, M. A. C., Araujo, A. S., Saad, S. T. O., Costa, F. F., Menzel, S., et al. (2016) · British Journal of Haematology · doi:10.1111/bjh.13961 · Cited by 33
“…adults have been identified: one residing within the b-globin gene cluster (‘XmnI-HBG2’) and two within enhancer elements regulating the haematopoietic transcription factors, BCL11A and MYB (HBSIL-MYB, also designated ‘HMIP-2’[HBS1L-MYB intergenic polymorphism (HMIP) block 2]) (Thein et al, 2009).”
BackgroundSelf-citationGenetic regulation of fetal haemoglobin in inherited bone marrow failure syndromes
Alter, B. P., Rosenberg, P. S., Day, T. G., Menzel, S., Giri, N., Savage, S. A., & Thein, S. L. (2013) · British Journal of Haematology · doi:10.1111/bjh.12399 · Cited by 32
“Whereas these 3 QTLs have been shown to be very important determinants of Hb F levels in patients with haemoglobinopathies and in healthy adults (Thein et al, 2009), the potential role of these QTLs in modulating elevated Hb F levels in patients with an IBMFS has not been previously reported.”
InfluentialSelf-citationStudying the altered timing of physiological events during development: It's about time…or is it?
Spicer, J. I., Rundle, S. D., & Tills, O. (2011) · Respiratory Physiology & Neurobiology · doi:10.1016/j.resp.2011.06.005 · Cited by 32
Genomic approaches to identifying targets for treating β hemoglobinopathies
Ngo, D., & Steinberg, M. H. (2015) · BMC Medical Genomics · doi:10.1186/s12920-015-0120-2 · Cited by 32
Foetal haemoglobin and the dynamics of paediatric malaria
Billig, E., McQueen, P. G., & McKenzie, F. E. (2012) · Malaria Journal · doi:10.1186/1475-2875-11-396 · Cited by 32
“Sickle cell anaemia and β-thalassaemia are generally accompanied by elevated HbF levels, but the degree of elevation is highly variable [39,40].”
BackgroundFetal globin gene inducers: novel agents and new potential
Perrine, S. P., Castañeda, S. A., Chui, D. H. K., Faller, D. V., BERENSON, R. J., Siritanaratku, N., & Fucharoen, S. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05593.x · Cited by 31
Costa, F. C., Fedosyuk, H., Chazelle, A. M., Neades, R. Y., & Peterson, K. R. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1003155 · Cited by 30
“Although the HPFH phenotype produced by the 2566 c-globin HPFH point mutation was weak, it was still at a level therapeutic for the treatment of hemoglobinopathies [23].”
Time Domains of Hypoxia Responses and -Omics Insights
Yu, J. J., Non, A. L., Heinrich, E. C., Gu, W., Alcock, J., Moya, E. A., Lawrence, E. S., Tift, M. S., O’Brien, K. A., Storz, J. F., et al. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.885295 · Cited by 30
“The use of compounds such as hydroxyurea have also been shown to promote HbF expression in sickle cell disease patients (Cokic et al., 2003).”
InfluentialStroke in sickle cell anemia patients: A need for multidisciplinary approaches
Menaa, F. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.05.006 · Cited by 30
“In spite of HU treatment efficacy in SCA patients, primarily through the induction of HbF, the exact mechanisms by which HU activates HbF remain unclear.”
BackgroundInfluentialDadheech, S., Jain, S., MadhuLatha, D. M., Sharma, V., Joseph, J., Jyothy, A., & Munshi, A. (2014) · Molecular Biology Reports · doi:10.1007/s11033-014-3195-5 · Cited by 28
“There is no evidence for dominance at the locus based on statistical analysis, which suggests an additive effect of the T allele of Xmn1 polymorphism [25].”
BackgroundNkya, S. W., Mgaya, J., Singh, T., Mariki, H., Rooks, H., Soka, D., Mmbando, B. P., Thein, S. L., Barrett, J. C., Makani, J., et al. (2015) · BMC Medical Genetics · doi:10.1186/s12881-015-0148-3 · Cited by 28
“Confirming our own previous findings [9,15] and replicating what is seen across human populations [4,6-13], we detected trait association over the entire region, with the peak signal (P < 10) located at the HMIP-2 locus (Figure 1, Table 1).”
BackgroundSelf-citationNkya, S. W., Mwita, L. A., Mgaya, J., Kumburu, H. H., van Zwetselaar, M., Menzel, S., Mazandu, G. K., Sangeda, R. Z., Chimusa, E. R., & Makani, J. (2020) · BMC Medical Genetics · doi:10.1186/s12881-020-01059-1 · Cited by 27
Self-citationScholz, H., & Kirschner, K. M. (2011) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2011.00004 · Cited by 27
“These include the synthesis of a fetal form of hemoglobin with improved oxygen binding affinity, a high cardiac output in relation to the effective oxygen needs, and a relatively low specific metabolic rate of most embryonic tissues (Martin, 2008; Thein et al., 2009).”
BackgroundGlobal Genetic Architecture of an Erythroid Quantitative Trait Locus,HMIP-2
Menzel, S., Rooks, H., Zélénika, D., Nkya, S. W., Gnanakulasekaran, A., Drašar, E., Cox, S. E., Liu, L., Masood, M., Silver, N., et al. (2014) · Annals of Human Genetics · doi:10.1111/ahg.12077 · Cited by 26
“HMIP-2-controlled traits, such as red cell number, size, and hemoglobin content, in addition to F cell increase and HbF persistence, are thought to arise through the intervention of cMYB in the kinetics of erythropoiesis (Thein et al., 2009).”
BackgroundSelf-citationBhanushali, A. A., Patra, P. K., Nair, D., Verma, H. K., & Das, B. R. (2014) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2014.10.003 · Cited by 26
Dai, Y., Sangerman, J., Luo, H., Fucharoen, S., Chui, D. H. K., Faller, D. V., & Perrine, S. P. (2015) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2015.10.004 · Cited by 26
“[5, 48-65] While concern has been raised regarding prolonged suppression of BCL11A on B-cell differentiation long-term in the context of gene editing approaches, these and other small molecules can be readily administered intermittently, thereby preventing sustained off-target effects.”
What influences Hb fetal production in adulthood?
Carrocini, G. C. S., Zamaro, P. J. A., & Bonini-Domingos, C. R. (2011) · Revista Brasileira de Hematologia e Hemoterapia · doi:10.5581/1516-8484.20110059 · Cited by 26
“The HBS1L gene is involved in the regulation of several cellular processes and is expressed in hematopoietic cells, whereas the MYB gene is involved in oncogenesis and plays a key role in the erythropoiesis process.(25,37) It is believed that a gene in the 6q region is responsible for encoding a factor involved in the…”
BackgroundInfluentialDiamantidis, M. D., Ikonomou, G., Argyrakouli, I., Pantelidou, D., & Delicou, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252211886 · Cited by 25
“Deletions or point mutations in the proximal promoter of γ -globin genes ( HBG1 , HBG2 ) have been linked to high γ -globin gene expression and HPFH [11].”
Research in Sickle Cell Disease: From Bedside to Bench to Bedside
Cisneros, G. S., & Thein, S. L. (2021) · HemaSphere · doi:10.1097/hs9.0000000000000584 · Cited by 26
Self-citationMohammad, S. N. N. A., Iberahim, S., Rahman, W. S. W. A., Hassan, M. N., Edinur, H. A., Azlan, M., & Zulkafli, Z. B. (2022) · Diagnostics · doi:10.3390/diagnostics12061374 · Cited by 25
Wonkam, A., & Hurst, S. (2014) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2013.0167 · Cited by 25
“A few genomic loci that have been consistently associated with increased levels of HbF influenced the clinical severity of SCD (Lettre et al., 2008; Thein et al., 2009).”
Gholampour, M. A., Asadi, M., Naderi, M., Azarkeivan, A., Soleimani, M., & Atashi, A. (2020) · Molecular Biology Reports · doi:10.1007/s11033-020-05483-7 · Cited by 26
Modarres, M., Shariati, L., Hejazi, Z., Shahbazi, M., Tabatabaiefar, M. A., & Khanahmad, H. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26412 · Cited by 24
“8–10 However, the use of these drugs has some serious adverse effect such as neurological complications or escalation of platelet concentration.(8,10) Therefore, development of new strategies for reactivation of HbF with less adverse effects is essential to improve life quality in patients with β-thalassemia.”
BackgroundFetal Haemoglobin and β -globin Gene Cluster Haplotypes among Sickle Cell Patients in Chhattisgarh
Bhagat, S., Patra, P. K., & Thakur, A. S. (2013) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2013/4381.2744 · Cited by 23
“[25] Thein SL, Menzel S, Lathrop M, Garner C.”
BackgroundA phase 2 trial of HQK-1001 in HbE-β thalassemia demonstrates HbF induction and reduced anemia
Patthamalai, P., Fuchareon, S., Chaneiam, N., Ghalie, R., Chui, D. H. K., Boosalis, M. S., & Perrine, S. P. (2014) · Blood · doi:10.1182/blood-2013-11-538470 · Cited by 23
MBD2 contributes to developmental silencing of the human ε-globin gene
Rupon, J. W., Wang, S. Z., Gnanapragasam, M. N., Labropoulos, S. V., & Ginder, G. D. (2011) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2011.01.001 · Cited by 23
“The exact mechanisms of this process are not yet fully understood; however, it has been shown to involve multiple interactions between cis elements, erythroid specific trans factors, ubiquitous trans factors, and epigenetic signals [41,42,49,54].”
BackgroundGeneration of a genomic reporter assay system for analysis of γ‐ and β‐globin gene regulation
Chan, K., Xu, J., Wardan, H., McColl, B., Orkin, S. H., & Vadolas, J. (2012) · The FASEB Journal · doi:10.1096/fj.11-199356 · Cited by 23
“15), as well as the region between the HBS1 gene HBS1L and the oncogene MYB (16, 17).”
BackgroundRoy, P., Bhattacharya, G., Mandal, A., Dasgupta, U. B., Banerjee, D., Chandra, S., & Das, M. (2012) · Hemoglobin · doi:10.3109/03630269.2012.735626 · Cited by 23
“associated with expression of Hb F in adults, and thus amelioration of disease severity of β-thal in various populations of European, North American, AfroCaribbean, Afro-German, Chinese and Southeast Asian descent (1,2,7).”
BackgroundMODULATING EFFECT OF THE ?158 G? (C?T) XMN-1 POLYMORPHISM IN INDIAN SICKLE CELL PATIENTS
Pandey, S., Pandey, S., Mishra, R. M., & Saxena, R. (2012) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2012.001 · Cited by 23
Kwiatkowski, J. L., Cohen, A. R., Garro, J., Alvarez, O. A., Nagasubramanian, R., Sarnaik, S. A., Thompson, A. A., Woods, G. M., Schultz, W. H., Mortier, N. A., et al. (2011) · American Journal of Hematology · doi:10.1002/ajh.22228 · Cited by 22
Genetic Modifiers at the Crossroads of Personalised Medicine for Haemoglobinopathies
Stephanou, C., Tamana, S., Minaidou, A., Papasavva, P. L., Kleanthous, M., & Kountouris, P. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8111927 · Cited by 21
“A large number of genome-wide analyses across diverse ethnic populations identified three quantitative trait loci (QTL) modulating Hb F levels: a promoter variant of the Gγ-globin gene (XmnI-HBG2), the HBS1L-MYB intergenic region (HMIP) and BCL11A, which together explain up to 50% of the genetic variation in Hb F [14,…”
BackgroundBianchi, N., Cosenza, L. C., Lampronti, I., Finotti, A., Breveglieri, G., Zuccato, C., Fabbri, E., Marzaro, G., Chilin, A., Angelis, G. D., et al. (2016) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-016-0187-2 · Cited by 21
Metadata
- Authors
- Thein, S. L., Menzel, S., Lathrop, M., & Garner, C.
- Affiliations
- King's College London (GB)
- Commissariat à l'Énergie Atomique et aux Énergies Alternatives (FR)
- University of California, Irvine (US)
- Corresponding author
- Thein, S. L.
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-10-06
- Volume
- 18
- Issue
- R2
- Pages
- R216-R223
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- PMC
- PMC2758709
- OpenAlex
- W2121678970
- Semantic Scholar
- 24f312a7a63abd9a348d7cd92da05ea68713d111
- Cited by
- 250
- References
- 64
- Citations by year
- 2026: 7 · 2025: 13 · 2024: 10 · 2023: 9 · 2022: 12 · 2021: 10 · 2020: 15 · 2019: 15 · 2018: 10 · 2017: 24 · 2016: 16 · 2015: 19 · 2014: 19 · 2013: 15 · 2012: 16
- FWCI
- 2.21
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Human Molecular Genetics (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Research Portal (King's College London) (submittedVersion)
- Funders
- National Heart, Lung, and Blood Institute (R01HL069259, R01-HL69259-03)
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Hemoglobin structure and function
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- fetal hemoglobin, sickle cell disease, beta-thalassemia, hereditary persistence of fetal hemoglobin, quantitative trait loci, HBG2, HBS1L-MYB, BCL11A, beta-globin gene, HBB mutations, genome-wide association study, positional cloning, candidate genes, cell proliferation and differentiation
- MeSH terms
- Animals, Erythrocytes, Fetal Hemoglobin, Humans, Genetic Variation, Quantitative Trait, Heritable, Genomics, Quantitative Trait Loci
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.